Fulya Doganer

Fulya Doganer

Auto-generated profile, based on publicly available information

Fulya Doganer

Faculty of Sciences and Arts, Molecular Biology and Genetics Department, University of Aksaray, Aksaray, Turkey

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2025 in Plasmonics
Verified
Journal Article
Open access
PDF file
SGSemih Gökdağ
Semih Gökdağ
FCFatma Caf
Fatma Caf
FDFulya Doğaner
Fulya Doğaner
BKBülent KAYA
Bülent KAYA
GAGurkan Aykutoglu
Gurkan Aykutoglu
Plantago lanceolata is a traditional medicinal plant that has attracted significant interest from researchers due to the use of its physiologically active components, particularly polyphenolics (flavonoids, hydroxycinnamic acids), in various fields. The aim of this study is to synthesize iron oxide (PLE@FeNPs) nanoparticles using a green synthesis approach with Plantago lanceolata (P. lanceolata) leaf extracts, characterize them, evaluate their in vitro effects, and assess their use in the removal of Congo red (CR) from wastewater. We carried out the physicochemical characterization of the nanoparticles using UV–Vis, FT-IR, and XRD spectroscopies; TEM and SEM microscopy; and Zetasizer particle size analysis. While the distinct peaks in XRD confirm the crystalline structure, TEM has determined an average particle size (8 nm) for PLE@NPs with deformed spherical nanoparticles. The FT-IR spectra showed that bioactive compounds from P. lanceolata were involved in the participation of PLE@FeNPs. EDX confirmed the presence of iron in the designed PLE@FeNPs. The antibacterial, antioxidant, and anticancer analyses of the studied PLE@FeNPs revealed significant activities. We investigated the adsorption kinetics of CR on PLE@FeNPs, taking into account initial dye concentration, different pH levels, adsorbent dosages, and temperature. At optimal conditions (concentration, 50 ppm; dosage, 15 mg; pH, 8), the degradation of CR dye in sunlight was found to be 99%. The small size of PLE@NPs (8 nm) and the more negative zeta potential (− 12.2 mV) support this situation. The equilibrium data demonstrated a good fit to the Langmuir isotherm model, outperforming the Freundlich isotherm model. The results showed that the pseudo-second-order kinetic model accurately described the kinetic data. PLE@NPs exhibited significant antioxidant, antimicrobial, and anticancer activities. This situation suggests that the nanocomposition of PLE@NPs obtained through the green route may have improved efficiency due to various synergistic effects. Overall, these results pave the way for further applications in dye removal and biological applications of environmentally friendly PLE@FeNPs. Graphical Abstract

1 January 2019 in Clinics
Verified
Journal Article
Open access
PDF file
MOMerih Ozgen
Merih Ozgen
DCDidem Turgut Cosan
Didem Turgut Cosan
FDFulya Doganer
Fulya Doganer
ASAhu SOYOCAK
Ahu SOYOCAK
OAOnur Armagan
Onur Armagan
FMFezan Sahin Mutlu
Fezan Sahin Mutlu
In this study, the relationship between osteoporotic vertebral fractures and 9041 Guanine/Adenine and 3673 Guanine/Adenine polymorphisms related to the vitamin K epoxide reductase complex subunit-1 (VKORC1) gene in postmenopausal women with osteoporosis was investigated. DNA was isolated from blood samples collected from 150 women with postmenopausal osteoporosis. Genotyping of the two polymorphic regions (9041 Guanine/Adenine and 3673 Guanine/Adenine) in VKORC1 was performed using polymerase chain reaction-restriction fragment length polymorphism analysis. The presence of radiographic fractures among the 150 patients was ascertained by using the Genant method. At least one fracture was detected in 98 patients, and no fracture was observed in 52 patients on radiological images. We found no association between the 9041 Guanine/Adenine (p=0.283) and 3673 Guanine/Adenine (p=0.232) polymorphisms of the VKORC1 gene and the development of secondary postosteoporotic fractures in our study. There was no relationship between osteoporotic vertebral fracture and VKORC1 gene polymorphism in a postmenopausal Turkish population.


1 November 2024 in Nucleosides, Nucleotides & Nucleic Acids
Verified
Journal Article
Closed access
FDFulya Doğaner
Fulya Doğaner
ASAhu SOYOCAK
Ahu SOYOCAK
DCDidem Turgut Coşan
Didem Turgut Coşan
MÖMerih Özgen
Merih Özgen
FBFunda Berkan
Funda Berkan
HGHasan Veysi Güneş
Hasan Veysi Güneş
Osteoporosis is a common age-related skeletal disease, characterized by changes in the microarchitectural structure of bone tissue and decreased bone mass, especially affecting postmenopausal women. Genetic and environmental factors affecting bone metabolism play a role in the development of osteoporosis. Methylenetetrahydrofolate reductase (MTHFR) is an important enzyme involved in the conversion of homocysteine to methionine. Genetic variations in the MTHFR gene lead to impaired function or inactivation of this enzyme. A decrease in MTHFR enzyme activity and an increase in homocysteine levels affect bone metabolism. In this study, we aimed to investigate the relationship between C677T and A1298C polymorphisms and osteoporosis in Turkish postmenopausal women. DNA samples were extracted from 200 volunteers. The PCR-RFLP technique was used to identify the MTHFR gene polymorphisms C677T and A1298C. The statistical significance of the analysis's results was assessed. C677T genotype and allele frequency distributions were not statistically different between postmenopausal osteoporosis and healthy control groups (p = 0.249, p = 0.754), while A1298C genotype and allele frequency distributions were found to be statistically significant (p = 0.002, p = 0.013). The results of our study showed that the A1298C polymorphism may be a genetic factor associated with osteoporosis in this specific population. However, the C677T polymorphism did not show a significant connection. To gain a more comprehensive understanding of the genetic basis of osteoporosis, future research with larger sample sizes and the consideration of additional genetic and environmental factors is essential. Additionally, it is crucial to account for ethnic disparities, gene-gene interactions, and gene-environment interplays. These insights can inform the development of personalized preventive and therapeutic strategies for individuals at risk of osteoporosis in diverse populations.